{
"NDC": {
"NDCCode": "72205-200-30",
"PackageDescription": "30 TABLET in 1 BOTTLE (72205-200-30) ",
"NDC11Code": "72205-0200-30",
"ProductNDC": "72205-200",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Roflumilast",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Roflumilast",
"DosageFormName": "TABLET",
"RouteName": "ORAL",
"StartMarketingDate": "20220907",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA208256",
"LabelerName": "Novadoz Pharmaceuticals LLC",
"SubstanceName": "ROFLUMILAST",
"StrengthNumber": "500",
"StrengthUnit": "ug/1",
"Pharm_Classes": "Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2024-08-29",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20220924",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}